- Home
- NVVEW vs SRPT Comparison
NVVEW vs SRPT Comparison
Compare NVVEW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVEW | SRPT |
|---|---|---|
| Founded | N/A | 1980 |
| Country | China | United States |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.3B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | NVVEW | SRPT |
|---|---|---|
| Price | $0.01 | $21.56 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 29 |
| Target Price | N/A | ★ $26.23 |
| AVG Volume (30 Days) | N/A | ★ 3.7M |
| Earning Date | N/A | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,413,715,000.00 |
| Revenue This Year | N/A | $13.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.15 |
| 52 Week Low | N/A | $10.42 |
| 52 Week High | N/A | $129.84 |
Technical Indicators
Market Signals| Indicator | NVVEW | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 55.25 |
| Support Level | $0.01 | $20.76 |
| Resistance Level | $0.02 | $22.85 |
| Average True Range (ATR) | 0.00 | 1.20 |
| MACD | -0.00 | 0.26 |
| Stochastic Oscillator | 16.51 | 74.47 |
Price Performance
Historical ComparisonAbout NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.